SUZANNE MORRIS: Open Payments
NPI 1043814304 · JACKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 44 payments from 16 companies in 2025. Trend: 2023 $1,631 · 2024 $1,808 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $156 |
| ABBVIE INC. | 10 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $115 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| E.R. Squibb & Sons, L.L.C. | 3 | $76 |
| Lilly USA, LLC | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $29 |
| Seqirus USA Inc | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
Products named: VRAYLAR, CAPLYTA, Ozempic, Wegovy, FARXIGA, CAMZYOS, MOUNJARO, ELIQUIS.
Industry payments across TN — which companies pay providers there.
